Yale Center for Metabolic Phenotyping in Live Models of Obesity and Diabetes
Yale Center for Metabolic Phenotyping in Live Models of Obesity and Diabetes
批准号:
10579071
负责人:
GERALD I SHULMAN
金额:
$79.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2028-01-31
关键词:
AnimalsAreaBiomedical ResearchClientCollaborationsCommunitiesComplexData AnalysesData Storage and RetrievalDiabetes MellitusExperimental DesignsExtramural ActivitiesFundingGoalsGuidelinesInternshipsLearningLiverMetabolicMetabolic DiseasesMetadataMethodologyMethodsModelingMonitorMusObesityPhenotypePhysiologicalProtocols documentationQuality ControlReproducibilityResearchResearch PersonnelResourcesServicesStandardizationTechnologyTestingTrainingUnderrepresented MinorityWorkbehavioral phenotypingcomplex datacostdata formatdata standardsdigital object identifierdiversity and equityempowermenthealth equity promotionmetabolic phenotypeminority investigatormouse geneticsmouse modeloperationprogramsscreeningtesting servicesweb-based tool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overarching goal of the Yale MPMOD is to provide extramural investigators access to the unique metabolic
phenotyping services provided by the Yale MPMOD and empower them to harness the power of mouse genetics
to its fullest potential to metabolically phenotype their mouse models of obesity and diabetes. The Yale MPMOD
consists of three highly interactive Cores that have an established (>20 yr) track record of working together in
close harmony: 1) The Yale MPMOD Administrative Core oversees the operation of the Yale MPMOD,
facilitates research with the other MPMOD Centers and the MPMOD Coordinating Unit to standardize key
methodologies, and coordinates the efficient workflow through the Yale MPMOD cores and access to the Yale
MPMOD Animal Core and the Yale MPMOD Phenotyping Core, 2) The Yale MPMOD Animal Core provides
a centralized facility for coordinating receiving, screening and monitoring mice from outside investigators and 3)
The Yale MPMOD Phenotyping Core empowers Yale MPMOD clients with access to unique metabolic phenotyping
services that provides them with the means to characterize the metabolic changes in their particular mouse models
of complex metabolic disease using established state-of-the-art methodology. The Specific Aims of the Yale
MPMOD are to: 1) serve the US academic research community to study diabetes and obesity in their mouse
models by providing metabolic, physiologic, and behavioral phenotyping on live mice, as well as expert advice
in mouse models, experiment design, data analysis, and data interpretation at similar cost whether inside or
outside Yale without bias and, and collaborate to provide a wide array of tests and expert advice while avoiding
unnecessary overlap, 2) Establish a Yale MPMOD Vibrant Program, which will work with the other national
MPMODs and the MPMOD Coordinating Unit to promote health equity and diversity in the US biomedical
research enterprise by supporting underrepresented minority investigators to succeed in biomedical research in
the areas of diabetes and obesity, via resources such as test services, pilot funding, expert advice on
experimental design, and/or short internships at the Yale MPMOD to learn test technologies, 3) Promote rigor
and reproducibility in research by: a) developing and sharing validated protocols for phenotyping live mice; b)
providing difficult experimental tests conducted by experts with a high degree of standardization and quality
control, to PIs who would otherwise not be able to conduct or afford them; and c) sharing technologies and
providing web-based tools for gold-standard approaches in experimental methods and data analysis, 4). Develop
standardized data formats and storage guidelines for complex data, including metadata, for sharing with clients
and the public as appropriate, and employ unique Research Resource identifiers (RRID), Digital Object
Identifiers (DOI), and other best practices directed by DKNet.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10579072
-
项目类别:
-
资助金额:$15.36万
-
财政年份:2023
-
负责人:GERALD I SHULMAN
-
依托单位:
Phenotyping Core
-
批准号:10579074
-
项目类别:
-
资助金额:$60.48万
-
财政年份:2023
-
负责人:GERALD I SHULMAN
-
依托单位:
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
-
批准号:9894796
-
项目类别:
-
资助金额:$53.85万
-
财政年份:2019
-
负责人:GERALD I SHULMAN
-
依托单位:
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
-
批准号:10352445
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2019
-
负责人:GERALD I SHULMAN
-
依托单位:
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1
-
批准号:10093992
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2018
-
负责人:GERALD I SHULMAN
-
依托单位:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
-
批准号:9763549
-
项目类别:
-
资助金额:$72.94万
-
财政年份:2017
-
负责人:GERALD I SHULMAN
-
依托单位:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
-
批准号:9361162
-
项目类别:
-
资助金额:$73.4万
-
财政年份:2017
-
负责人:GERALD I SHULMAN
-
依托单位:
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
-
批准号:10217114
-
项目类别:
-
资助金额:$72.94万
-
财政年份:2017
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8545824
-
项目类别:
-
资助金额:$121.97万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8310171
-
项目类别:
-
资助金额:$127.1万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8150940
-
项目类别:
-
资助金额:$128.1万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8050303
-
项目类别:
-
资助金额:$125.97万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance
-
批准号:8728821
-
项目类别:
-
资助金额:$125.53万
-
财政年份:2010
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:6814748
-
项目类别:
-
资助金额:$136.46万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:7285973
-
项目类别:
-
资助金额:$139.78万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:6948596
-
项目类别:
-
资助金额:$139.02万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:7122474
-
项目类别:
-
资助金额:$139.8万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Mitochrondrial Dysfunction: Role in Metabolic Syndrome
-
批准号:7493559
-
项目类别:
-
资助金额:$141.1万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
Role of Mitochondrial Dysfunction in Insulin Resistance
-
批准号:6844965
-
项目类别:
-
资助金额:$14.32万
-
财政年份:2004
-
负责人:GERALD I SHULMAN
-
依托单位:
DIFFERENCES BETWEEN INSULIN RESISTANT AND NON-INSULIN RESISTANT INDIVIDUALS
-
批准号:7206855
-
项目类别:
-
资助金额:$5.12万
-
财政年份:2003
-
负责人:GERALD I SHULMAN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: